Display Settings:

Format

Send to:

Choose Destination
    Infect Immun. 2004 Mar;72(3):1557-67.

    Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia.

    Source

    Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, National Institute for Medical Research, Mill Hill, London, United Kingdom.

    Abstract

    Antibodies to the C terminus of the Plasmodium falciparum merozoite surface protein, PfMSP-1(19), may inhibit merozoite invasion or block the effects of inhibitory antibodies. Here, using a competition enzyme-linked immunosorbent assay and antibody binding to wild-type and mutated recombinant proteins, we show that there are marked variations between individuals in the fine specificity of naturally acquired anti-MSP-1(19) antibodies. Furthermore, although neither the prevalence nor the concentration of total anti-MSP-1(19) antibodies was associated with resistance to malaria in African children, significant associations were observed between antibody fine specificity and subsequent risk of infection and high-density parasitemia during a follow-up period. Thus, the fine specificity of naturally acquired human anti-MSP-1(19) antibodies is crucial in determining their function. Future field studies, including the evaluation of PfMSP-1 vaccine trials, should include assays that explore antibody fine specificity as well as titer.

    PMID:
    14977962
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC356041
    Free PMC Article

    Images from this publication.See all images (4) Free text

    FIG. 1.
    FIG. 3.
    FIG. 2.
    FIG. 4.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk